Zucchi, Elisabetta
 Distribuzione geografica
Continente #
NA - Nord America 3.976
AS - Asia 3.075
EU - Europa 1.944
SA - Sud America 476
AF - Africa 72
OC - Oceania 6
Totale 9.549
Nazione #
US - Stati Uniti d'America 3.838
SG - Singapore 959
CN - Cina 879
IT - Italia 744
BR - Brasile 349
VN - Vietnam 315
HK - Hong Kong 292
GB - Regno Unito 235
SE - Svezia 158
DE - Germania 152
BD - Bangladesh 134
KR - Corea 132
FI - Finlandia 126
RU - Federazione Russa 109
FR - Francia 103
ID - Indonesia 80
IN - India 72
CA - Canada 62
NL - Olanda 61
AR - Argentina 49
LT - Lituania 38
MX - Messico 34
IQ - Iraq 31
IE - Irlanda 27
BG - Bulgaria 26
JP - Giappone 26
PL - Polonia 26
CZ - Repubblica Ceca 25
ES - Italia 24
TR - Turchia 21
ZA - Sudafrica 21
EC - Ecuador 20
AT - Austria 18
CO - Colombia 18
UA - Ucraina 18
UZ - Uzbekistan 16
SA - Arabia Saudita 14
AE - Emirati Arabi Uniti 13
MY - Malesia 12
CH - Svizzera 11
JM - Giamaica 11
MA - Marocco 11
VE - Venezuela 11
EG - Egitto 10
PK - Pakistan 10
CL - Cile 9
TN - Tunisia 9
TW - Taiwan 9
BE - Belgio 8
KE - Kenya 7
PH - Filippine 7
AZ - Azerbaigian 6
CR - Costa Rica 6
JO - Giordania 6
PY - Paraguay 6
RO - Romania 6
UY - Uruguay 6
LB - Libano 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
AU - Australia 4
BH - Bahrain 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
HN - Honduras 4
IL - Israele 4
OM - Oman 4
PA - Panama 4
PE - Perù 4
DK - Danimarca 3
DZ - Algeria 3
GR - Grecia 3
IR - Iran 3
LV - Lettonia 3
NO - Norvegia 3
NP - Nepal 3
PS - Palestinian Territory 3
SN - Senegal 3
AL - Albania 2
BB - Barbados 2
BZ - Belize 2
CY - Cipro 2
ET - Etiopia 2
GT - Guatemala 2
HR - Croazia 2
KH - Cambogia 2
MK - Macedonia 2
MT - Malta 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
DJ - Gibuti 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 9.538
Città #
Singapore 614
Ashburn 553
Santa Clara 538
Hefei 364
Hong Kong 290
San Jose 271
Fairfield 255
Chandler 208
Beijing 134
Seoul 124
London 109
Los Angeles 97
Ho Chi Minh City 91
Woodbridge 90
Council Bluffs 89
Helsinki 89
Nyköping 88
Seattle 85
Houston 84
Milan 82
Modena 78
Hanoi 71
The Dalles 70
Cambridge 69
Wilmington 68
New York 67
Jakarta 60
Chicago 57
Munich 54
Southend 51
Bologna 48
Rome 42
Buffalo 39
San Diego 37
Shanghai 32
Ann Arbor 31
Lauterbourg 31
Moscow 30
Dearborn 28
São Paulo 27
Hillsboro 26
Orem 26
Sofia 25
Frankfurt am Main 24
Princeton 22
Tokyo 21
Turku 21
Warsaw 21
Bremen 20
Da Nang 20
Kent 20
Piscataway 20
Atlanta 19
Boardman 19
Amsterdam 17
Dallas 16
Montreal 16
Lappeenranta 15
Mexico City 15
North Bergen 15
Phoenix 15
Toronto 14
Brno 13
Jacksonville 13
Tashkent 13
Dublin 12
Reggio Emilia 12
City of London 11
Manchester 11
Newark 11
Vienna 11
Florence 10
Johannesburg 10
Olomouc 10
Poplar 10
Redondo Beach 10
Secaucus 10
Tampa 10
Turin 10
Ankara 9
Bari 9
Biên Hòa 9
Chennai 9
Haiphong 9
Hangzhou 9
Nuremberg 9
Rio de Janeiro 9
Salt Lake City 9
Clifton 8
Denver 8
Eugene 8
New Delhi 8
Brasília 7
Bắc Ninh 7
Guarulhos 7
Norwalk 7
Ottawa 7
Parma 7
Quito 7
Reading 7
Totale 6.028
Nome #
Riluzole and other prognostic factors in ALS: a population-based registry study in Italy 347
Cerebrospinal Fluid Neurofilaments May Discriminate Upper Motor Neuron Syndromes: A Pilot Study 339
Post-infectious sensory neuropathy with anti-GT1a and GQ1b antibodies associated with cold urticaria 332
Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study 313
Proteostasis and ALS: Protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS) 300
Epidemiological, Clinical and Genetic Features of ALS in the Last Decade: A Prospective Population-Based Study in the Emilia Romagna Region of Italy 297
High‐frequency motor rehabilitation in amyotrophic lateral sclerosis: a randomized clinical trial 290
Clinical and Lifestyle Factors and Risk of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study 270
Predictors for progression in amyotrophic lateral sclerosis associated to SOD1 mutation: insight from two population-based registries 264
Pearls & Oy-sters: Paroxysmal dysarthria-ataxia syndrome: Acoustic analysis in a case of antiphospholipid syndrome 261
Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis: Clinical Protocol and Evaluation of Microbiota Immunity Axis 253
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 244
Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trial 240
Clinical features and outcomes of the flail arm and flail leg and pure lower motor neuron MND variants: A multicentre Italian study 238
Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study 234
Duplication of exons 15 and 16 in Matrin-3: a phenotype bridging amyotrophic lateral sclerosis and immune-mediated disorders 227
SerpinA1 levels in amyotrophic lateral sclerosis patients: An exploratory study 224
Case report: p.Glu134del SOD1 mutation in two apparently unrelated ALS patients with mirrored phenotype 223
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 213
A novel p.N66T mutation in exon 3 of the SOD1 gene: report of two families of ALS patients with early cognitive impairment 208
Reply to comment on “environmental and occupational risk factors of amyotrophic lateral sclerosis: A population-based case-control study” 202
Amyotrophic lateral sclerosis stratification: unveiling patterns with virome, inflammation, and metabolism molecules 192
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study. 192
Insight into Elderly ALS Patients in the Emilia Romagna Region: Epidemiological and Clinical Features of Late-Onset ALS in a Prospective, Population-Based Study 186
Factors predicting disease progression in C9ORF72 ALS patients 183
Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data 175
Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers 175
The association between lifelong personality and clinical phenotype in the FTD-ALS spectrum 169
CSF Heavy Neurofilament May Discriminate and Predict Motor Neuron Diseases with Upper Motor Neuron Involvement 167
A Variant in TBCD Associated with Motoneuronopathy and Corpus Callosum Hypoplasia: A Case Report 165
The gut microbiota-immunity axis in als: A role in deciphering disease heterogeneity? 161
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial 160
Multifaceted superoxide dismutase 1 expression in amyotrophic lateral sclerosis patients: a rare occurrence? 157
G507D mutation in FUS gene causes familial amyotrophic lateral sclerosis with a specific genotype-phenotype correlation. 153
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis 152
Young Onset Alzheimer’s Disease Associated with C9ORF72 Hexanucleotide Expansion: Further Evidence for a Still Unsolved Association 152
Neurodegenerative and neuroinflammatory changes in SOD1-ALS patients receiving tofersen 150
Phenotypical Characterization of C9ALS Patients from the Emilia Romagna Registry of ALS: A Retrospective Case–Control Study 147
Trends in Hospital Admissions for Patients with Amyotrophic Lateral Sclerosis: Insights from a Retrospective Cohort Study in a Province in Northern Italy 146
Reduced levels of neurosteroids in cerebrospinal fluid of amyotrophic lateral sclerosis patients 145
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis 137
Exploring the Role of Diabetes in ALS: A Population-Based Cohort Study 126
The landscape of cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosis 124
Psychiatric Symptoms in Amyotrophic Lateral Sclerosis: Beyond a Motor Neuron Disorder 124
Trapianto di microbiota fecale nella Sclerosi Laterale Amiotrofica: effetti clinici e biologici di un trial clinico randomizzato 111
Tregs levels and phenotype modifications during Amyotrophic Lateral Sclerosis course 108
Withdrawal of mechanical ventilation in amyotrophic lateral sclerosis patients: a multicenter Italian survey 101
Predictors from systemic and neuro-inflammation in amyotrophic lateral sclerosis: A monocentric experience 97
Circulating Serum Cell-Free Mitochondrial DNA in Amyotrophic Lateral Sclerosis 67
Totale 9.641
Categoria #
all - tutte 40.401
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.401


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022453 40 32 19 13 11 23 13 14 73 50 104 61
2022/2023553 63 71 29 51 67 73 9 54 64 15 27 30
2023/2024565 11 15 36 44 69 30 83 65 13 38 58 103
2024/20252.269 53 24 59 182 357 320 150 86 285 124 280 349
2025/20264.670 440 247 398 545 561 211 565 308 449 477 281 188
2026/2027291 291 0 0 0 0 0 0 0 0 0 0 0
Totale 9.641